Adesis Inc. is a premier 100% US-based Contract Development and Manufacturing Organisation (CDMO) that accelerates its clients’ success by integrating the innovation of a clean technology company into the biotech, pharmaceutical, and specialty chemical industries. With a technical expertise in high purity monomers, heterocycles, and deuterium, Adesis Inc. serves as a direct extension of its clients’ R&D teams. The company offers innovative, agile, and integrated drug discovery collaboration aimed at delivering high purity, quantity, and speed to meet the complex needs of the pharmaceutical sector.

Services include:
– Regulatory Services
– Active Pharmaceutical Ingredients (APIs)
– Contract Development and Manufacturing (CDMO)
– Finished Dosage Forms
– Specialty Manufacturing
– Organic and Organometallic Synthesis
– Early-stage Research
– Scale-up and Development

Adesis Inc. stands out as a trusted partner in the pharmaceutical industry, committed to advancing research and manufacturing goals through its comprehensive range of services. For more information, please visit adesisinc.com.